(PharmaNewsWire.Com, March 18, 2017 ) According to Publisher, the Medical Radiation Detection Market accounted for $0.87 billion in 2015 and is expected to reach $1.58 billion by 2022 growing at a CAGR of 8.8% from 2015 to 2022. Increasing incidences of cancer and rising healthcare industry worldwide...
(PharmaNewsWire.Com, March 20, 2017 ) According to Publisher, the Global Polymerase Chain Reaction market is accounted for $6.95 billion in 2015 and is expected to reach $12.56 billion by 2022 growing at a CAGR of 8.8% during the forecast period. Increasing investments in gene therapy and government...
(PharmaNewsWire.Com, March 20, 2017 ) According to Publisher, the Bone Marrow Transplant market accounted for $10.58 billion in 2015 and is expected to reach $15.95 billion by 2022 growing at a CAGR of 6.0% from 2015 to 2022. Occurrence of blood cancers and increasing investment in logistic services...
(PharmaNewsWire.Com, March 20, 2017 ) According to Publisher, the Global Nuclear Medicine Market is valued at $4.42 billion in 2015 and is expected to grow at a CAGR of 10.55 % to reach $8.92 billion by 2022. Rising demand from emerging nations and the growing incidence of cardiovascular ailments...
(PharmaNewsWire.Com, March 20, 2017 ) According to Publisher, the Global Medical Alert Systems market is estimated at $5.48 billion in 2015 and is expected to grow at a CAGR of 7.8% to reach $9.27 billion by 2022. In time of emergency to provide assistance by healthcare individuals the medical systems...
(PharmaNewsWire.Com, March 20, 2017 ) According to Publisher, the Global Electronic Medical Records market is accounted for $24.02 billion in 2015 and is expected to reach $36.5 billion by 2022 growing at a CAGR of 6.05% from 2015 to 2022. Growing incidence for number of diseases and rapidly increasing...
(PharmaNewsWire.Com, March 20, 2017 ) According to Publisher, the Cord Blood Banking Services market accounted for $12.50 billion in 2015 and is expected to grow at a CAGR of 6.41% to reach $19.32 billion by 2022. The factors such as increasing stem cell therapy applications in diseased treatments,...
(PharmaNewsWire.Com, March 20, 2017 ) According to Publisher, the Global Human Microbiome Market is accounted for $130.23 million in 2015 and is expected to reach $521.23 million by 2022 growing at a CAGR of 21.9% during the forecast period. Increasing incidence of lifestyle diseases, growing geriatric...
(PharmaNewsWire.Com, March 18, 2017 ) According to Publisher, the Global Radiotherapy Device market is accounted for $5.5 billion in 2015 and is expected to reach $9.1 billion by 2022 growing at a CAGR of 7.4% from 2015 to 2022. Radiotherapy being a painless treatment, increase in cancer patients...
(PharmaNewsWire.Com, March 18, 2017 ) According to Publisher, the Global Next Generation Sequencing market is estimated at $3.41 billion in 2015 and is expected to reach $13.50 billion by 2022 growing at a CAGR of 21.73% from 2015 to 2022. The growing adoption of sequencing technologies in clinical...
Persistence Market Research(PharmaNewsWire.Com, March 18, 2017 ) According to the latest market report published by Persistence Market Research, titled “Global Market Study on Scar Treatment: Rising awareness of personal care and increased demand of clinically evidenced Topical products to drive...
Persistence Market Research(PharmaNewsWire.Com, March 18, 2017 ) Polymerase chain reaction is a medical device used in genetics, genetic engineering and molecular biology research. These are used to amplify single or copy of a piece of DNA (deoxyribonucleic acid). Polymerase chain reaction technologies...
Persistence Market Research(PharmaNewsWire.Com, March 18, 2017 ) HIV-AIDS is a chronic disease caused by the human immunodeficiency virus (HIV). HIV virus damages human immune system, which results weakness of immune system and loss ability to fight with organism that causes disease. HIV-AIDS most...
Persistence Market Research(PharmaNewsWire.Com, March 18, 2017 ) Neurological devices industry is growing at a significant rate due to increase in the prevalence of neurological injuries and diseases. Neurological devices may be invasive in nature such as intracranial pressure monitors, which are...
(PharmaNewsWire.Com, March 18, 2017 ) Diabetes is the chronic condition associated with abnormally high level of glucose in the blood. Insufficient or non production of insulin in pancreas causes diabetes. Globally the incidence of diabetes is increasing significantly and it is becoming a major...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
